ExodusPoint Capital Management’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-457	Closed	-$3K	–	1865
2025 Q2	$3K	Buy	+457	New	+$4.02K	﹤0.01%	1404
2025 Q1	–	Sell	-7,766	Closed	-$278K	–	1814
2024 Q4	$278K	Buy	+7,766	New	+$402K	﹤0.01%	1298
2024 Q3	–	Sell	-4,287	Closed	-$215K	–	1934
2024 Q2	$215K	Buy	+4,287	New	+$310K	﹤0.01%	1384
2023 Q2	–	Sell	-1,601	Closed	-$165K	–	2119
2023 Q1	$165K	Buy	1,601 +1,129	+239%	+$158K	﹤0.01%	1595
2022 Q4	$69K	Sell	472 -5,824	-93%	-$984K	﹤0.01%	1535
2022 Q3	$1.06M	Buy	6,296 +5,275	+517%	+$857K	0.01%	1083
2022 Q2	$118K	Sell	1,021 -10,063	-91%	-$946K	﹤0.01%	1729
2022 Q1	$1.11M	Buy	11,084 +9,868	+812%	+$1.15M	0.02%	1086
2021 Q4	$189K	Buy	+1,216	New	+$237K	﹤0.01%	1843
2021 Q3	–	Sell	-846	Closed	-$287K	–	2448
2021 Q2	$287K	Buy	+846	New	+$320K	﹤0.01%	1770
2021 Q1	–	Sell	-1,308	Closed	-$870K	–	2431
2020 Q4	$870K	Sell	1,308 -490	-27%	-$272K	0.01%	933
2020 Q3	$837K	Buy	+1,798	New	+$908K	0.02%	764
2019 Q2	–	Sell	-2,180	Closed	-$287K	–	1262
2019 Q1	$287K	Buy	+2,180	New	+$274K	0.02%	478